Sean Dodge
Stock Analyst at RBC Capital
(3.19)
# 1,269
Out of 4,583 analysts
157
Total ratings
43.44%
Success rate
1.87%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TBRG TruBridge | Reiterates: Outperform | $14 | $12.23 | +14.47% | 3 | Sep 17, 2024 | |
| CDMO Avid Bioservices | Maintains: Outperform | $8 → $12 | $11.42 | +5.08% | 13 | Sep 10, 2024 | |
| WAY Waystar Holding | Maintains: Outperform | $27 → $31 | $26.85 | +15.46% | 1 | Sep 6, 2024 | |
| PHR Phreesia | Reiterates: Sector Perform | $23 | $24.05 | -4.37% | 13 | Sep 5, 2024 | |
| HQY HealthEquity | Reiterates: Outperform | $92 | $77.54 | +18.65% | 11 | Sep 4, 2024 | |
| IQV IQVIA Holdings | Initiates: Outperform | $275 | $242.67 | +13.32% | 1 | Sep 4, 2024 | |
| EVH Evolent Health | Reiterates: Outperform | $42 | $30.84 | +36.19% | 6 | Aug 26, 2024 | |
| OPRX OptimizeRx | Maintains: Outperform | $17 → $14 | $7.68 | +82.29% | 9 | Aug 16, 2024 | |
| GDRX GoodRx Holdings | Reiterates: Outperform | $10 | $7.35 | +36.05% | 12 | Aug 16, 2024 | |
| PRVA Privia Health Group | Reiterates: Outperform | $28 | $19.07 | +46.83% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $8 | $3.99 | +100.50% | 5 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $17 | $16.74 | +1.55% | 9 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $9 | $9.09 | -0.99% | 14 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $11.66 | +20.07% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $64 | $60.32 | +5.27% | 16 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $19 | $14.18 | +33.99% | 12 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $69 → $62 | $61.70 | +0.49% | 8 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $13 → $8 | $8.74 | -8.47% | 7 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $197.63 | -83.30% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $66 → $12 | $0.21 | +5,486.59% | 2 | Mar 9, 2022 |
TruBridge
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $12.23
Upside: +14.47%
Avid Bioservices
Sep 10, 2024
Maintains: Outperform
Price Target: $8 → $12
Current: $11.42
Upside: +5.08%
Waystar Holding
Sep 6, 2024
Maintains: Outperform
Price Target: $27 → $31
Current: $26.85
Upside: +15.46%
Phreesia
Sep 5, 2024
Reiterates: Sector Perform
Price Target: $23
Current: $24.05
Upside: -4.37%
HealthEquity
Sep 4, 2024
Reiterates: Outperform
Price Target: $92
Current: $77.54
Upside: +18.65%
IQVIA Holdings
Sep 4, 2024
Initiates: Outperform
Price Target: $275
Current: $242.67
Upside: +13.32%
Evolent Health
Aug 26, 2024
Reiterates: Outperform
Price Target: $42
Current: $30.84
Upside: +36.19%
OptimizeRx
Aug 16, 2024
Maintains: Outperform
Price Target: $17 → $14
Current: $7.68
Upside: +82.29%
GoodRx Holdings
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $7.35
Upside: +36.05%
Privia Health Group
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $19.07
Upside: +46.83%
Aug 7, 2024
Reiterates: Outperform
Price Target: $8
Current: $3.99
Upside: +100.50%
Aug 6, 2024
Reiterates: Outperform
Price Target: $17
Current: $16.74
Upside: +1.55%
Aug 1, 2024
Maintains: Outperform
Price Target: $18 → $9
Current: $9.09
Upside: -0.99%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $11.66
Upside: +20.07%
Jul 11, 2024
Reiterates: Sector Perform
Price Target: $64
Current: $60.32
Upside: +5.27%
Jun 28, 2024
Reiterates: Outperform
Price Target: $19
Current: $14.18
Upside: +33.99%
Jun 4, 2024
Downgrades: Sector Perform
Price Target: $69 → $62
Current: $61.70
Upside: +0.49%
Oct 30, 2023
Maintains: Sector Perform
Price Target: $13 → $8
Current: $8.74
Upside: -8.47%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $197.63
Upside: -83.30%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $66 → $12
Current: $0.21
Upside: +5,486.59%